latest news in companies
European Regulators Approve Sanofi Meningitis Vaccine for Infants as Young as Six Weeks
Paris, Tuesday, 4 August 2026.
The European Commission expanded approval for Sanofi’s MenQuadfi vaccine to six-week-old infants, broadening early protection against a rapid, severe disease carrying a mortality rate up to 15 percent.
Nurix Therapeutics Begins Pivotal Phase 3 Trial Testing Novel Leukemia Treatment Against Key Competitor
San Francisco, Tuesday, 4 August 2026.
On August 4, 2026, Nurix Therapeutics enrolled the first patient in a Phase 3 trial evaluating its targeted protein degrader, bexobrutideg, head-to-head against Eli Lilly’s pirtobrutinib for chronic leukemia.
Finland's IQM Quantum Computers Reports First Public Earnings With over €102 Million Order Backlog
Espoo, Tuesday, 4 August 2026.
IQM Quantum Computers delivered its inaugural earnings report as a public company, showcasing a massive €102.1 million order backlog that highlights surging demand for commercial quantum hardware.
Eli Lilly Drug Earns Fast-Track FDA Status for Pancreatic Cancer
Indianapolis, Tuesday, 4 August 2026.
Eli Lilly received FDA Breakthrough Therapy designation for olomorasib to treat advanced pancreatic cancer. This marks the drug’s second fast-track status, addressing a fatal condition with no current approved targeted options.
Chinese Regulators Fast-Track Promising Two-Drug Combination for Blood Cancer Treatment
Beijing, Tuesday, 4 August 2026.
China fast-tracked InnoCare’s dual-drug therapy for blood cancer after clinical trials demonstrated a 100% response rate, significantly accelerating the approval process for this innovative treatment.
Kalaris Therapeutics Under Investigation Over Board Conduct Before Restructuring
New York, Tuesday, 4 August 2026.
Abbott Cooper PLLC has launched an investigation into Kalaris Therapeutics board members regarding potential breaches of fiduciary duty toward long-term shareholders prior to major corporate restructuring.
Cogent Communications Faces Investor Lawsuits After Stock Drops 80%
Washington, Tuesday, 4 August 2026.
Cogent Communications faces securities class-action lawsuits following allegations that it misleadingly promoted its optical wavelength order backlog, contributing to an over 80% stock collapse and a 98% dividend cut.
Major U.S. Corporations Face Investor Class Actions After Multi-Billion Dollar Stock Drops
Seattle, Tuesday, 4 August 2026.
Litigation firm Hagens Berman has filed securities class action lawsuits against several major U.S. companies following misleading financial reports, failed clinical trials, and sudden operational disruptions that wiped out billions in shareholder value.